Clinical Trial Update: A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021 [Phase 3]

View source ↗

Summary

Open-label extension study of teduglutide in subjects who completed a prior study for short bowel syndrome; completed Phase 3 trial with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Short Bowel Syndrome

Drugs mentioned

• Teduglutide (teduglutide)

Snippet

Sponsor: Shire | Conditions: Short Bowel Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2014-12-25